Spots Global Cancer Trial Database for Ascorbic Acid Levels in MDS, AML, and CMML Patients

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Ascorbic Acid Levels in MDS, AML, and CMML Patients

Official Title: Collection of Peripheral Blood From Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia for Measuring Baseline Ascorbic Acid Levels and Future Epigenetic Cancer Research

Study ID: NCT03526666

Conditions

Myelodysplastic Syndromes

Acute Myeloid Leukemia

Chronic Myelomonocytic Leukemia

MDS

AML

CMML

Interventions

Peripheral blood collection

Study Description

Brief Summary: This study is a non-interventional, specimen collection translational study to evaluate vitamin C levels in the peripheral blood of Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), or Chronic Myelomonocytic Leukemia (CMML) patients.

Detailed Description: It has previously been established that hematological cancer patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) often exhibit severe vitamin C deficiency from a cohort of patients in Copenhagen. In this study, the investigators aim to determine if those results are conserved in another population/geographical location.